These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 35658904)
1. Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines. Amari DT; Juday T; Frech FH; Wang W; Wu Z; Atkins N; Wickwire EM BMC Geriatr; 2022 Jun; 22(1):484. PubMed ID: 35658904 [TBL] [Abstract][Full Text] [Related]
2. Fall Risk, Healthcare Resource Use, and Costs Among Adult Patients in the United States Treated for Insomnia with Zolpidem, Trazodone, or Benzodiazepines: A Retrospective Cohort Study. Amari DT; Juday TR; Frech FH; Wang W; Gor D; Atkins N; Wickwire EM Adv Ther; 2022 Mar; 39(3):1324-1340. PubMed ID: 35072889 [TBL] [Abstract][Full Text] [Related]
3. Incremental health care resource use and costs among adult patients with depression and treated for insomnia with zolpidem, trazodone, or benzodiazepines. Wickwire EM; Amari DT; Juday TR; Frech F; Gor D; Malhotra M Curr Med Res Opin; 2022 May; 38(5):711-720. PubMed ID: 35262444 [TBL] [Abstract][Full Text] [Related]
4. Zolpidem Versus Trazodone Initiation and the Risk of Fall-Related Fractures among Individuals Receiving Maintenance Hemodialysis. Assimon MM; Flythe JE Clin J Am Soc Nephrol; 2020 Dec; 16(1):88-97. PubMed ID: 33355192 [TBL] [Abstract][Full Text] [Related]
5. Benzodiazepine Usage, Healthcare Resource Utilization, and Costs Among Older Adults Treated with Common Insomnia Medications: A Retrospective Cohort Study. Wickwire EM; Juday TR; Gor D; Amari DT; Frech FH Clinicoecon Outcomes Res; 2023; 15():413-424. PubMed ID: 37287898 [TBL] [Abstract][Full Text] [Related]
6. Prescription Medications for the Treatment of Insomnia and Risk of Suicide Attempt: a Comparative Safety Study. Lavigne JE; Hur K; Kane C; Au A; Bishop TM; Pigeon WR J Gen Intern Med; 2019 Aug; 34(8):1554-1563. PubMed ID: 31161572 [TBL] [Abstract][Full Text] [Related]
7. Economic burden of comorbid insomnia in 5 common medical disease subgroups. Wickwire EM; Juday TR; Kelkar M; Heo J; Margiotta C; Frech FH J Clin Sleep Med; 2023 Jul; 19(7):1293-1302. PubMed ID: 37394794 [TBL] [Abstract][Full Text] [Related]
8. Untreated insomnia increases all-cause health care utilization and costs among Medicare beneficiaries. Wickwire EM; Tom SE; Scharf SM; Vadlamani A; Bulatao IG; Albrecht JS Sleep; 2019 Apr; 42(4):. PubMed ID: 30649500 [TBL] [Abstract][Full Text] [Related]
9. Real-World Characteristics and Treatment Patterns of Patients With Insomnia Prescribed Trazodone in the United States. Pochiero I; Gorini M; Comandini A; Calisti F; Loreto GD; Cattaneo A; Knight T; Anastassopoulos KP; Patel R; Baik R; Bruni O Clin Ther; 2022 Aug; 44(8):1093-1105. PubMed ID: 36041931 [TBL] [Abstract][Full Text] [Related]
10. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States. Jhaveri M; Seal B; Pollack M; Wertz D Curr Med Res Opin; 2007 Jun; 23(6):1431-43. PubMed ID: 17559740 [TBL] [Abstract][Full Text] [Related]
11. Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant. Kale HP; Qureshi ZP; Shah R; Khandker R; Botteman M; Meng W; Benca R Adv Ther; 2021 Oct; 38(10):5221-5237. PubMed ID: 34463922 [TBL] [Abstract][Full Text] [Related]
13. Psychiatric comorbidities and prescribing tendencies of sleep medications and related medications in young people with insomnia: a United States commercial claims-based analysis. Bushnell G; Ivanenko A; Horton DB; Lunsford-Avery JR; Posner J; Gerhard T; Suarez E; Olfson M Sleep; 2024 May; 47(5):. PubMed ID: 38430553 [TBL] [Abstract][Full Text] [Related]
14. Mortality and concurrent use of opioids and hypnotics in older patients: A retrospective cohort study. Ray WA; Chung CP; Murray KT; Malow BA; Daugherty JR; Stein CM PLoS Med; 2021 Jul; 18(7):e1003709. PubMed ID: 34264928 [TBL] [Abstract][Full Text] [Related]
15. Health care resource utilization and costs among individuals with vs without Huntington disease in a US population. To TM; Exuzides A; Abbass IM; Patel AM; Ta JT; Surinach A; Fuller RLM; Luo J J Manag Care Spec Pharm; 2022 Nov; 28(11):1228-1239. PubMed ID: 36282937 [No Abstract] [Full Text] [Related]
16. Ruxolitinib for myelofibrosis in elderly non-transplant patients: healthcare resource utilization and costs. Gerds AT; Yu J; Shah A; Xi A; Kumar S; Scherber R; Parasuraman S J Med Econ; 2023; 26(1):843-849. PubMed ID: 37294103 [TBL] [Abstract][Full Text] [Related]
17. Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals. Best JH; Reddy SR; Chang E; Bognar K; Tarbox MH; Cagas SE; Seetasith A J Med Econ; 2024; 27(1):240-252. PubMed ID: 38294309 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and cost of insomnia in a state Medicaid fee-for-service population based on diagnostic codes and prescription utilization. Roy AN; Smith M Sleep Med; 2010 May; 11(5):462-9. PubMed ID: 20363670 [TBL] [Abstract][Full Text] [Related]
19. Hypnosedative use and predictors of successful withdrawal in new patients attending a falls clinic: a retrospective, cohort study. Joester J; Vogler CM; Chang K; Hilmer SN Drugs Aging; 2010 Nov; 27(11):915-24. PubMed ID: 20964465 [TBL] [Abstract][Full Text] [Related]
20. Risk of in-hospital falls among medications commonly used for insomnia in hospitalized patients. Herzig SJ; Rothberg MB; Moss CR; Maddaleni G; Bertisch SM; Wong J; Zhou W; Ngo L; Anderson TS; Gurwitz JH; Marcantonio ER Sleep; 2021 Sep; 44(9):. PubMed ID: 33710329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]